CCR7 and T-cell leukemia: Finally, there are many mutations in the C-terminal cytoplasmic domain of CCR7 relevant to adult T-cell leukemia/lymphoma, and mutation at the Trp355* residue was shown to prevent CCR7 internalization, resulting in increased surface receptor expression and a gain of chemotaxis function (Kataoka et al., 2015).